# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cadence's best-in-class Integrity 3D-IC platform supercharged with new featuresRevolutionary AI-driven digital and custom/a...
To gain an edge, this is what you need to know today.
ABEO: -55% | Abeona Therapeutics shares are trading lower after the company announced the FDA issued a Complete Response Letter...
Needham analyst Charles Shi reiterates Cadence Design Sys (NASDAQ:CDNS) with a Buy and maintains $320 price target.